• 1
    Undas A, Ariens RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol 2011; 12: e8899.
  • 2
    Blomback B, Okada M. Fibrin gel structure and clotting time. Thromb Res 1982; 25: 5170.
  • 3
    Sugo T, Nakamikawa C, Yoshida N, Niwa K, Sameshima M, Mimuro J, Weisel JW, Nagita A, Matsuda M. End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extension lead to fragile clot structure. Blood 2000; 96: 377985.
  • 4
    Lim BC, Ariens RA, Carter AM, Weisel JW, Grant PJ. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 2003; 361: 142431.
  • 5
    Marchi R, Meyer M, De Bosch NB, Soria J, Arocha-Pinango CL, Weisel JW. Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen. Blood Coagul Fibrinolysis 2004; 15: 28593.
  • 6
    Marchi R, Arocha-Pinango CL, Nagy H, Matsuda M, Weisel JW. The effects of additional carbohydrate in the coiled-coil region of fibrinogen on polymerization and clot structure and properties: characterization of the homozygous and heterozygous forms of fibrinogen Lima (Aalpha Arg141-->Ser with extra glycosylation). J Thromb Haemost 2004; 2: 9408.